Literature DB >> 10694236

Different role of IL-4 in the onset of hapten-induced contact hypersensitivity in BALB/c and C57BL/6 mice.

H Nagai1, Y Ueda, T Ochi, Y Hirano, H Tanaka, N Inagaki, K Kawada.   

Abstract

1. To study the role of interleukin (IL)-4 in the onset of contact hypersensitivity (CH) in mice, the effect of IL-4 gene-depletion and anti-IL-4 monoclonal antibody treatment on dinitrofluorobenzene (DNFB)-induced CH was examined. Simultaneously, to clarify the effect of background gene, DNFB-induced CH in BALB/c and C57BL/6 mice was compared. 2. Five repeated topical applications of DNFB to the ears of mice resulted in CH of the ears in terms of increases in ear thickness and histopathological changes. The magnitude of ear thickness increase in BALB/c mice was almost three times greater than that in C57BL/6 mice. 3. The CH in BALB/c mice was significantly suppressed by IL-4 gene-depletion and anti-IL-4 monoclonal antibody treatment. In contrast, the symptoms of dermatitis in C57BL/6 mice were slightly affected by the same treatment. These changes corresponded well to the production of specific IgE antibody. 4. Total IgE antibody production and the expression of productive Cepsilon mRNA were dramatically suppressed by IL-4 gene-depletion and anti-IL-4 treatment in BALB/c and C57BL/6 mice. Neither total IgG nor IgM levels in either strain of mice was altered by depletion of IL-4. 5. The expression of IFN-gamma in the skin lesion was dramatically suppressed by IL-4 gene-depletion in BALB/c mice, but not in C57BL/6 mice. 6. These findings indicate that IL-4 plays an important role in the onset of DNFB-induced CH in BALB/c mice, but not in C57BL/6 mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694236      PMCID: PMC1571838          DOI: 10.1038/sj.bjp.0703054

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

1.  Anti-inflammatory action of IL-4. Negative regulation of contact sensitivity to trinitrochlorobenzene.

Authors:  S C Gautam; N F Chikkala; T A Hamilton
Journal:  J Immunol       Date:  1992-03-01       Impact factor: 5.422

2.  Induction of germ-line and mature C epsilon transcripts in human B cells stimulated with rIL-4 and EBV.

Authors:  H H Jabara; L C Schneider; S K Shapira; C Alfieri; C T Moody; E Kieff; R S Geha; D Vercelli
Journal:  J Immunol       Date:  1990-11-15       Impact factor: 5.422

3.  IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice.

Authors:  R I Tepper; D A Levinson; B Z Stanger; J Campos-Torres; A K Abbas; P Leder
Journal:  Cell       Date:  1990-08-10       Impact factor: 41.582

4.  Germline and productive C epsilon gene expression during in vivo IgE responses.

Authors:  G Thyphronitis; I M Katona; W C Gause; F D Finkelman
Journal:  J Immunol       Date:  1993-10-15       Impact factor: 5.422

5.  Immunoglobulin E production in mice by means of contact sensitization with a simple chemical, hapten.

Authors:  H Nagai; A Matsuo; H Hiyama; N Inagaki; K Kawada
Journal:  J Allergy Clin Immunol       Date:  1997-12       Impact factor: 10.793

6.  Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis.

Authors:  Q Hamid; M Boguniewicz; D Y Leung
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

7.  Osteoporosis induced in mice by overproduction of interleukin 4.

Authors:  D B Lewis; H D Liggitt; E L Effmann; S T Motley; S L Teitelbaum; K J Jepsen; S A Goldstein; J Bonadio; J Carpenter; R M Perlmutter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

8.  IL-4 is essential for the systemic transfer of delayed hypersensitivity by T cell lines. Role of gamma/delta cells.

Authors:  F Dieli; G L Asherson; G C Romano; G Sireci; F Gervasi; A Salerno
Journal:  J Immunol       Date:  1994-03-15       Impact factor: 5.422

9.  Interleukin-9 potentiates the interleukin-4-induced IgE and IgG1 release from murine B lymphocytes.

Authors:  C Petit-Frere; B Dugas; P Braquet; J M Mencia-Huerta
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

10.  Specificity of immunoglobulin heavy chain switch correlates with activity of germline heavy chain genes prior to switching.

Authors:  J Stavnezer-Nordgren; S Sirlin
Journal:  EMBO J       Date:  1986-01       Impact factor: 11.598

View more
  6 in total

1.  A targeted mutation in the IL-4Ralpha gene protects mice against autoimmune diabetes.

Authors:  D L Radu; N Noben-Trauth; J Hu-Li; W E Paul; C A Bona
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  Topical application of a phospholipid mixture purified from pig lungs ameliorates 2,4-dinitrofluorobenzene-induced allergic contact dermatitis in BALB/c mice.

Authors:  Jeong-Su Moon; Byung-Suk Jeon; Byung-Il Yoon; Seong-Hyun Choi; Chang-Jin Lim
Journal:  Mol Biol Rep       Date:  2011-07-20       Impact factor: 2.316

3.  Cathelicidin antimicrobial peptides inhibit hyaluronan-induced cytokine release and modulate chronic allergic dermatitis.

Authors:  Yasuhide Morioka; Kenshi Yamasaki; Donald Leung; Richard L Gallo
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

4.  Interleukin-4-dependent innate collaboration between iNKT cells and B-1 B cells controls adaptative contact sensitivity.

Authors:  Regis A Campos; Marian Szczepanik; Atsuko Itakura; Mariette Lisbonne; Neelendu Dey; Maria C Leite-de-Moraes; Philip W Askenase
Journal:  Immunology       Date:  2006-04       Impact factor: 7.397

5.  SH2 domain-containing phosphatase 2 is a critical regulator of connective tissue mast cell survival and homeostasis in mice.

Authors:  Namit Sharma; Vijay Kumar; Stephanie Everingham; Raghuveer Singh Mali; Reuben Kapur; Li-Fan Zeng; Zhong-Yin Zhang; Gen-Sheng Feng; Karin Hartmann; Axel Roers; Andrew W B Craig
Journal:  Mol Cell Biol       Date:  2012-05-07       Impact factor: 4.272

6.  Dual role of interleukin-4 (IL-4) in pulmonary paracoccidioidomycosis: endogenous IL-4 can induce protection or exacerbation of disease depending on the host genetic pattern.

Authors:  Celina Arruda; Rita C Valente-Ferreira; Adriana Pina; Suely S Kashino; Raquel A Fazioli; Celidéia A C Vaz; Marcello F Franco; Alexandre C Keller; Vera L G Calich
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.